“…To investigate the efficiency of our strategy, we prepared 1, O-benzyl protected glucuronolactone derivative 2 8 , and a corresponding set of standard methyl glucuronate derivatives 3 13 and 4 14 as disarmed and armed counterparts with 4 C 1 conformation, respectively. As acceptors, hexosamine derivatives 5 15 , 6 16 and 7 17 were prepared to afford chondroitin sulfate (CS), hyaluronic acid (HA), and heparan sulfate (HS) type dissaccharide units in GAGs, respectively. (Fig.…”